Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Advances in Renal Replacement Therapy|February 15, 2001
Post-transplant diabetes: incidence, relationship to choice of immunosuppressive drugs, and treatment protocolM S MarkellDiabetes Care|September 1, 1992
Diabetic nephropathy. Management of the end-stage patientM S Markell, E A FriedmanThe American Journal of Medicine|November 1, 1989
Hyperlipidemia after organ transplantationM S Markell, E A FriedmanSeminars in Nephrology|May 1, 1990
Care of the diabetic patient with end-stage renal diseaseM S Markell, E A FriedmanAmerican Journal of Nephrology|January 1, 1992
Unrecognized pseudohyperkalemia as a cause of elevated potassium in patients with renal diseaseO Ifudu, M S Markell, E A FriedmanJournal of the American Society of Nephrology : JASN|February 1, 1994
Hyperlipidemia and glucose intolerance in the post-renal transplant patientM S Markell, V Armenti, G Danovitch, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1993
Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patientsM S Markell, N Sumrani, A DiBenedetto, et al.Cellular & Molecular Biology Research|January 1, 1993
Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activationJ B Fernandes, U P Naik, M S Markell, et al.Clinical Science (London, England : 1979)|September 1, 1993
Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levelsM S Markell, B T Altura, R L Barbour, et al.Transplantation|May 2, 2001
Common iliac artery stenosis presenting as renal allograft dysfunction in two diabetic recipientsS Aslam, M O Salifu, H Ghali, et al.Pageof 3